US 2004/0171593 A1Published application

Method and compositions for treating an inflammatory disease

AssigneeSmithKline Beecham Corporation

InventorsElizabeth T. Keating, James M. Kanagy

Life of this patent

Estimating the term…

Abstract

This invention relates to treating an inflammatory disease by administering a phosphodiesterase 4 inhibitor in combination with an inhibitor of prostaglandin synthesis, NSAIDs being exemplary.

Claims2

Dependent claims

A method for treating an inflammatory disease by administering to a patient in need thereof an effective amount of a PDE 4 inhibitor and a non-steroidal anti-inflammatory drug (NSAID) in a combined form, separately, or separately and sequentially where the sequential administration is close in time or remote in time.

Dependencies are inferred from the claim text.

Facts

Application: 10/796,658Filed 8 Mar 2004
Priority: 8 Feb 2000
Published: 2 Sep 2004
Term ends: Not estimatedThe source records don’t support an estimate.

Classification8 codes

A61K 31/277
Nitriles; Isonitriles: having a ring, e.g. verapamil
A61K 31/19
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids: carboxylic acids, e.g. valproic acid
A61K 31/192
Carboxylic acids, e.g. valproic acid: having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
A61K 31/40
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having five-membered rings with one nitrogen as the only ring hetero atom,…

Family

Application60/180,879Us provisional application · filed 8 Feb 2000
Application10/203,226Continuation · filed 7 Aug 2002
Application10/203,226A 371 of international · filed 7 Aug 2002
Application10/796,658Continuation · filed 8 Mar 2004
US 2003/0207845 A1Published application
US 2004/0171593 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

Abstract

This invention relates to treating an inflammatory disease by administering a phosphodiesterase 4 inhibitor in combination with an inhibitor of prostaglandin synthesis, NSAIDs being exemplary.

Facts

Application

10/796,658Filed 8 Mar 2004

Priority

8 Feb 2000

Published

2 Sep 2004

Term ends

Not estimatedThe source records don’t support an estimate.

Classification8 codes

A61K 31/277
Nitriles; Isonitriles: having a ring, e.g. verapamil
A61K 31/19
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids: carboxylic acids, e.g. valproic acid
A61K 31/192
Carboxylic acids, e.g. valproic acid: having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
A61K 31/40
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having five-membered rings with one nitrogen as the only ring hetero atom,…

Family

Application60/180,879Us provisional application · filed 8 Feb 2000

Application10/203,226Continuation · filed 7 Aug 2002

Application10/203,226A 371 of international · filed 7 Aug 2002

Application10/796,658Continuation · filed 8 Mar 2004

US 2003/0207845 A1Published application

US 2004/0171593 A1This patent

From the US filing history. Foreign family members aren’t listed.